Skip to content

Patient Specific Guides and Surgical Planning for Periacetabular Osteotomy; Post Marketing Evaluation Study

MyPAO Patient Specific Guides and Surgical Planning for Periacetabular Osteotomy; Post Marketing Evaluation Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06037278
Acronym
MyPAO
Enrollment
15
Registered
2023-09-14
Start date
2023-07-13
Completion date
2025-09-30
Last updated
2023-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acetabular Dysplasia, Pelvic Osteotomy, Periacetabular Osteotomy

Keywords

Customised surgical guides

Brief summary

A case series to provide post marketing evaluation of the MyPAO surgical planning and patient specific guides technology. This will be a single-centre, multi-surgeon evaluation assessing the safety of the use of these guides in periacetabular osteotomy surgery.

Detailed description

After enrolment, baseline data will be collected including age, sex and ethnicity of the participant. The radiographic measures of centre edge angle of Wiberg and acetabular inclination will be measured by the surgeon and patient reported outcome measures (PROMS) will be collected. The PROMS collected at usual care timepoints in patients undergoing pelvic osteotomy will be collated for use in the dataset. Peri-operative data, including clinician opinion on ease of use, intraoperative dose of radiation used and device associated adverse events, will be recorded and reported in the results.

Interventions

DEVICEMyPAO

use of MyPAO surgical guide to support periacetabular osteotomy procedures for treatment of acetabular dysplasia

Sponsors

The Royal Orthopaedic Hospital NHS Trust
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* · Age greater than 18 years * Patient undergoing pelvic osteotomy

Exclusion criteria

* · Evidence of hip degeneration assessed by the surgeon on x-ray (Tonnis Grade 1 or greater) * Known allergy to Polyamide PA12 * Unable to provide written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Product safety assessment3 months post-surgeryevaluate the use of the MyPAOTM technology by reviewing number of device related adverse events, in order to continue to assess product safety as part of post marketing surveillance.

Secondary

MeasureTime frameDescription
Proof of concept12 monthssurgeon questionnaires after each case. We will determine technical difficulties in using the device, surgeon satisfaction with the use of guides and the guided correction and the presence of any intra-operative adverse events.
i-hot12 questionnaire12 months post-surgeryhip-specific health related quality of life outcome tool
Eq-5D12 months post-surgeryvalidated measure of health-related quality of life

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026